PC HAS ONE OF THE LOWEST 5-YEAR SURVIVAL RATES AMONG ALL CANCER TYPES, REMAINING BELOW 10% FOR THE PAST 40…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- 75N91023C00015
- Contractor
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $354,959
- Period of performance
- Feb 27, 2023 – Feb 26, 2024
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN12
- Place of performance
- NY
Public award description
PC HAS ONE OF THE LOWEST 5-YEAR SURVIVAL RATES AMONG ALL CANCER TYPES, REMAINING BELOW 10% FOR THE PAST 40 YEARS, INDICATING A NEED FOR EFFECTIVE PC THERAPIES. STUDIES HAVE SHOWN THAT NMC-521 BINDS SELECTIVELY TO SEVERAL PC CELL LINES WITH MARKED ANT
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.